Literature DB >> 15356060

Multifunctional cells in human pituitary adenomas: implications for paradoxical secretion and tumorigenesis.

Laura Senovilla1, Lucía Núñez, José M de Campos, Daniel A de Luis, Enrique Romero, Ana Sánchez, Javier García-Sancho, Carlos Villalobos.   

Abstract

Pituitary adenomas are very common in humans. They are of monoclonal origin, very heterogeneous, and produce frequently paradoxical secretion. The normal anterior pituitary (AP) contains some unorthodox multifunctional cells able to store more than one AP hormone (polyhormonal) and/or to express multiple hypothalamic-releasing hormone receptors (multiresponsive). Multifunctional AP cells seem to be involved in plasticity processes such as transdifferentiation or paradoxical secretion. Here, we have characterized the single-cell phenotypes of 15 human pituitary tumors, including prolactinomas, nonfunctioning adenomas, and adenomas from multiple endocrine neoplasia type I (MEN-I) and pituitary Cushing's disease patients. Individual tumor cells were typed according to expression of AP hormones and hypothalamic-releasing hormone receptors by combination of calcium imaging and multiple sequential immunocytochemistry in the same cells. We found a large heterogeneity among the different tumors. In eight of the 15 tumors studied, more than 80% of the cells presented a multifunctional phenotype. This may explain the occurrence of paradoxical secretion. In addition, our results suggest that human pituitary adenomas might derive from multifunctional cells. This is consistent with the existence of a link between pituitary plasticity and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356060     DOI: 10.1210/jc.2004-0072

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Diethylstilbestrol increases the density of prolactin cells in male mouse pituitary by inducing proliferation of prolactin cells and transdifferentiation of gonadotropic cells.

Authors:  Keiko Shukuwa; Shin-Ichi Izumi; Yoshitaka Hishikawa; Kuniaki Ejima; Satoshi Inoue; Masami Muramatsu; Yasuyoshi Ouchi; Takashi Kitaoka; Takehiko Koji
Journal:  Histochem Cell Biol       Date:  2006-02-09       Impact factor: 4.304

2.  Transformation of a microprolactinoma into a mixed growth hormone and prolactin-secreting pituitary adenoma.

Authors:  Cédric Dessimoz; Patrick Browaeys; Philippe Maeder; Benoît Lhermitte; Nelly Pitteloud; Shahan Momjian; François P Pralong
Journal:  Front Endocrinol (Lausanne)       Date:  2012-01-12       Impact factor: 5.555

3.  Single-Cell Phenotypic Characterization of Human Pituitary GHomas and Non-Functioning Adenomas Based on Hormone Content and Calcium Responses to Hypothalamic Releasing Hormones.

Authors:  Laura Senovilla; Lucía Núñez; José María de Campos; Daniel A de Luis; Enrique Romero; Javier García-Sancho; Carlos Villalobos
Journal:  Front Oncol       Date:  2015-06-09       Impact factor: 6.244

4.  Gene expression profiling in human corticotroph tumours reveals distinct, neuroendocrine profiles.

Authors:  Maria Francesca Cassarino; Alberto G Ambrogio; Andrea Cassarino; Maria Rosa Terreni; Davide Gentilini; Antonella Sesta; Francesco Cavagnini; Marco Losa; Francesca Pecori Giraldi
Journal:  J Neuroendocrinol       Date:  2018-08-07       Impact factor: 3.627

5.  Store-operated Ca2+ entry and Ca2+ responses to hypothalamic releasing hormones in anterior pituitary cells from Orai1-/- and heptaTRPC knockout mice.

Authors:  Lucía Núñez; Gary S Bird; Elena Hernando-Pérez; Enrique Pérez-Riesgo; James W Putney; Carlos Villalobos
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-11-17       Impact factor: 5.011

6.  Proopiomelanocortin, glucocorticoid, and CRH receptor expression in human ACTH-secreting pituitary adenomas.

Authors:  Maria Francesca Cassarino; Antonella Sesta; Luca Pagliardini; Marco Losa; Giovanni Lasio; Francesco Cavagnini; Francesca Pecori Giraldi
Journal:  Endocrine       Date:  2016-05-24       Impact factor: 3.633

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.